Work

Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency

Year: 2022

Type: article

Source: Molecular Pharmaceutics

DOI: 10.1021/acs.molpharmaceut.2c00923

Authors: Sanghwan Ko, Man-Seok Ju, Hye-Mi Ahn, Jung-Hyun Na, Woo Hyung Ko, Migyeong Jo, Munsu Kyung, Chung Su Lim, Byoung Joon Ko, Won-Kyu Lee, Youn-Jae Kim, Sang Taek Jung

Institutions: Korea University, National Cancer Center, Sangji University, Osong Medical Innovation Foundation, Sungshin Women's University

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Center, National Research Foundation of Korea

Awards: G2579467062, G3340247035, G3737561125, G4886075403, G5702789435

OpenAlex ID: W4312129020

FWCI: 0.187

Cites: 42

Cited by: 3

Related to: 10